Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Vistagen Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 51 | 58 | +7 |
| Shares | 15.5M | 23.4M | +7.87M (+50.8%) |
| Value | $30.3M | $81.8M | +$51.5M (+170.2%) |
New holders (14)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Janus Henderson Group PLC | 4,165,767 | $14.7M | 0.01% |
| OrbiMed Advisors LLC | 3,060,000 | $10.9M | 0.26% |
| Soleus Capital Management, L.P. | 550,000 | $1.95M | 0.10% |
| Citadel Advisors LLC | 122,062 | $433.3K | 0.00% |
| XTX Topco Ltd | 69,712 | $247.5K | 0.01% |
| Walleye Capital LLC | 67,770 | $240.6K | 0.00% |
| Goldman Sachs Group Inc | 60,152 | $213.5K | 0.00% |
| Cubist Systematic Strategies, LLC | 43,953 | $156.0K | 0.00% |
| Occudo Quantitative Strategies LP | 42,704 | $151.6K | 0.02% |
| Gsa Capital Partners LLP | 31,486 | $112.0K | 0.01% |
| Millennium Management LLC | 20,676 | $73.4K | 0.00% |
| Quadrature Capital Ltd | 15,752 | $55.8K | 0.00% |
| Schonfeld Strategic Advisors LLC | 10,883 | $38.6K | 0.00% |
| FNY Investment Advisers, LLC | 6,000 | $21.0K | 0.01% |
Sold out (7)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Sphera Funds Management Ltd. | 447,939 | $895.9K |
| Marshall Wace, LLP | 34,638 | $69.3K |
| Virtu Financial LLC | 22,946 | $46.0K |
| Simplex Trading, LLC | 22,536 | $45.0K |
| Tower Research Capital LLC (TRC) | 7,721 | $15.4K |
| Raymond James Financial Inc | 6,410 | $12.8K |
| Royal Bank of Canada | 3,297 | $7.00K |